Advisory Panel.

  • - Allan Karr, Pharmacy Business Services Manager, University College Hospitals, London and Chairman of PDIG
  • - Philip Aubrey, Medicines Procurement Specialist Pharmacist, London and Eastern areas
  • - Jim Armstong, Senior Procurement Specialist Pharmacist, Kent and Medway, Surrey and Sussex
  • - Margaret Dolan, Pharmaceutical Adviser Pharmacologistics, Scotland
  • - Ron Pate, Pharmaceutical Consultant, Secondary Care Pharmaceutical Adviser, Keele University
  • - David Stead, Medicines Procurement Specialist Pharmacist, NHS South West
  • - Dr Julian Brown, General Practitioner, Norfolk



Previous Articles.

    • - The Business of Safe and Reliable NHS Medicines Supply
         Martin Sawer
    • - Centralised Procurement and Distribution of Medicines in a Large NHS Board in Scotland - The possible model for the future
         Norman Lannigan
    • - Impact of Medicine Homecare Services on Hospital Pharmacy Staff Resource
         Ron Pate
    • - Patient Access Schemes - How do they impact the NHS?
    • - Procurement in the NHS - A personal Overview from a Regional Procurement Pharmacist
         David Stead
    • - The Health we’re in
         Roy Lilley
    • - Contracting for branded medicines – current challengesand future strategies
         Peter Sharott
    • - A global strategic plan for Hospital Pharmacy
         Roger Tredree
    • - Issues facing the Homecare market
         Allan Karr
    • - Best practice in the implementation of homecare
         Services at the acute Trust level
         Michael Gains
    • - Purchasing for Safety
         Tim Root, Kevan Wind
    • - The challenges associated with developing therapies for rare diseases
         Suyash Prasad
    • - What are undergraduate pharmacy students taught about business and procurement?
         Stephen Curtis
    • - Stock supply issues in the UK Medicines Market
         Jeff Bulmer
    • - Orphan Drugs–Fulfilling an unmet need, but at what price?
         Donald Macarthur


Editorial Content.

The issues covered in the journal will be drawn from the expertise of the panel members and use their collective experience and knowledge to address the issues facing supply chain and procurement pharmacists. Comment on business environment issues will also be included.The pharmaceutical industry will be approached for sponsorship as appropriate.


Publication Format.

The British Journal of Medicines Procurement will be produced to the highest quality in A4.